Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biofrontera (BFRI) Current Leases (2022 - 2025)

Historic Current Leases for Biofrontera (BFRI) over the last 4 years, with Q3 2025 value amounting to $307000.0.

  • Biofrontera's Current Leases fell 5417.91% to $307000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $307000.0, marking a year-over-year decrease of 5417.91%. This contributed to the annual value of $548000.0 for FY2024, which is 2069.46% down from last year.
  • As of Q3 2025, Biofrontera's Current Leases stood at $307000.0, which was down 5417.91% from $443000.0 recorded in Q2 2025.
  • Over the past 5 years, Biofrontera's Current Leases peaked at $701000.0 during Q2 2024, and registered a low of $307000.0 during Q3 2025.
  • For the 4-year period, Biofrontera's Current Leases averaged around $546636.4, with its median value being $548000.0 (2024).
  • Its Current Leases has fluctuated over the past 5 years, first surged by 4256.2% in 2024, then crashed by 5417.91% in 2025.
  • Biofrontera's Current Leases (Quarter) stood at $498000.0 in 2022, then soared by 38.76% to $691000.0 in 2023, then decreased by 20.69% to $548000.0 in 2024, then tumbled by 43.98% to $307000.0 in 2025.
  • Its last three reported values are $307000.0 in Q3 2025, $443000.0 for Q2 2025, and $426000.0 during Q1 2025.